Immunotherapy scores first win against some breast cancers, but benefit is limited and cost is high
(Chicago Tribune Religion News)

For the first time, one of the new immunotherapy drugs has shown promise against breast cancer in a large study that combined it with chemotherapy to treat an aggressive form of the disease. But the benefit for most women was small, raising questions about whether the treatment is worth its high...